logo
GOP lawmaker moves to overhaul bill protecting drug discounts critical to some KY hospitals

GOP lawmaker moves to overhaul bill protecting drug discounts critical to some KY hospitals

Yahoo12-02-2025
Kentucky hospitals would be required to file data about their discounts from drug companies through the 340B program under an amendment sponsored by Sen. Gex Williams. (Getty Images)
A Northern Kentucky lawmaker has proposed a new version of a bill meant to protect a program that generates income for charity health care that some Kentucky hospitals say is essential for their survival.
'This is a very critical program for our hospitals and access to care in rural communities,' Nancy Galvagni, president of the Kentucky Hospital Association, told a legislative committee Feb. 5, referring to the federal 340B Drug Pricing Program.
But Sen. Gex Williams, R-Verona, has filed an amendment to Senate Bill 14 to replace it with a measure he said is critical to getting more information about how much money from the program, subsidized by the pharmaceutical industry, is generated and spent before further legislative action.
'It tries to collect some data so we can better understand what we're dealing with,' said Williams, whose legislative page describes him as an engineer and technology consultant. 'The data we collect will enable us to better ascertain the fiscal impact on the state of Kentucky.'
The program, which generates income for charity care from deep discounts drug manufacturers provide hospitals and other entities, such as health clinics, has come under fire from consumer advocates and the pharmaceutical industry for what they say is its rapid growth and lack of oversight.
'When hospitals, other covered entities and their contract pharmacies have free rein to mark up medicines, patients, employers and taxpayers across Kentucky pay the price,' Reid Porter, a spokesman for Pharmaceutical Research and Manufacturers of America, or PhRMA, said in an emailed statement. 'Transparency and accountability are needed to ensure 340B is being used appropriately.'
PhRMA, along with other groups including the Kentucky Association of Manufacturers, oppose SB 14 as filed by Sen. Stephen Meredith, R-Leitchfield and a former hospital CEO.
Meredith did not respond to a request for comment about the changes Williams proposes to SB 14. He has argued his SB14 would preserve an essential income stream especially important to rural hospitals in Kentucky.
At the Feb. 5 meeting of the Senate Health Services Committee he chairs, Meredith said his bill simply mirrors legislation passed in a handful of other states that prevents pharmaceutical companies from restricting drugs sold in Kentucky at discounts of up to 50%. He said some companies have begun imposing such restrictions that limit revenue to Kentucky providers.
'Why should we not be allowed to have this funding when other states do?' asked Meredith, who said it brings in about $122 million a year for Kentucky hospitals, clinics and other entities that serve low-income patients.
The Kentucky Hospital Association, which supports Meredith's bill, agrees.
While Williams' proposal may be 'intended to be helpful,' it doesn't account for how the program generates savings for hospitals by requiring manufacturers to provide them drugs 'at the same price the drug companies charge their best customers,' said Jim Musser, senior vice-president with the association.
'The savings generated from that discounted price allow the hospitals to put the savings toward stretching scarce resources,' he said.
Several supporters of the bill testified the 340B program is especially helpful for expanding access to costly cancer infusion drugs which can cost tens of thousands of dollars.
KY health care providers depend on drug discount program that's facing fire on several fronts
Williams said he hadn't discussed his amendment to SB 14 with Meredith other than to notify him he planned to file it.
'I'm presuming we'll discuss it in caucus,' Williams said, referring to the meeting of the Republican majority that controls the Senate. He said he doesn't know when it might be called on the floor for a vote after committee passage Feb. 5.
Williams' amendment would strip out Meredith's language from SB 14 and replace it with a bill that would require all hospitals and any affiliated facilities, such as health clinics, to file a detailed annual report with the Cabinet for Health and Family Services about how much money they gain from the program and how they use it.
The bill also would apply to 'contract' or outside pharmacies used by those hospitals and clinics which critics say have expanded rapidly to include major drugstore chains and industry middlemen known as pharmacy benefit managers or PBMs.
Williams said the legislature could consider changes to state law after it determines details about how much money the program generates and where it goes.
'I don't know how we can make a decision … without data,' he said.
Williams's proposal does not apply to clinics not affiliated with hospitals such as the state's system of 'safety-net' health clinics authorized by the federal government to provide care for low-income and uninsured patients.
Advocates for the about 30 such clinics across Kentucky had expressed alarm at potential reduction of the funds they say are vital to care they provide.
Molly Lewis, executive director of the Kentucky Primary Care Association, said the 340B program brings in about $19 million a year to the community health clinics, funds she said are essential to caring for patients who can't pay for services.
'We support Senate Bill 14,' she said, referring to Meredith's original bill.
Meanwhile, some advocates continue to seek reforms at the federal level since the federal government oversees the program.
Meredith has said he agrees overall change must come from Congress, which is considering proposals to tighten controls and improve oversight of the 340B program. His bill, he said, is meant to protect Kentucky health providers in the meantime.
'I don't think there's a person involved in health care that realize there need to be some changes, some adjustments to it,' he said at the Feb. 5 hearing. 'But that's not why we're here today.'
SUBSCRIBE: GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Japan Tariff Deal: Trump Says U.S. Has Agreed To Reduced 15% Tariff Rate For Japan
Japan Tariff Deal: Trump Says U.S. Has Agreed To Reduced 15% Tariff Rate For Japan

Forbes

time2 hours ago

  • Forbes

Japan Tariff Deal: Trump Says U.S. Has Agreed To Reduced 15% Tariff Rate For Japan

The U.S. and Japan have reached a trade agreement that will lower tariff rates on the longtime U.S. ally down to 15%, President Donald Trump said Tuesday. Trump announced the deal Tuesday evening. (Photo by Doug Mills-Pool/Getty Images) Getty Images The 25% tariff rate slated to hit Japan by August will be lowered to 15%, according to Trump, who said Japan will invest $550 billion into the U.S. under the deal. This is a developing story. Check back for updates.

Asia-Pacific markets set to open higher after Trump hails Japan trade deal
Asia-Pacific markets set to open higher after Trump hails Japan trade deal

CNBC

time3 hours ago

  • CNBC

Asia-Pacific markets set to open higher after Trump hails Japan trade deal

Aerial view of Mt. Fuji, Tokyo Tower and modern skyscrapers in Tokyo on a sunny day. Yongyuan | E+ | Getty Images Asia-Pacific markets were set to open higher after U.S. President Donald Trump announced that he had completed a "massive Deal" with Japan, which set tariffs of 15% on the country's exports to the U.S. Overnight, the U.S. benchmark S&P 500 rose to another record high. Happy mid-week from Singapore! Asia markets were poised to open higher. Japan's benchmark Nikkei 225 was set to start the trading day higher, with the futures contract in Chicago at 40,185 against the index's last close at 39,774.92. Australia's S&P/ASX 200 was also on track to start the day higher with futures tied to the benchmark at 8,681, compared with its last close of 8,677.20. Futures for Hong Kong's Hang Seng index stood at 25,321, pointing to a stronger open compared with the HSI's last close of 25,130.03. — Lee Ying Shan The S&P 500 and the Dow Jones Industrial Average closed in the green on Tuesday. The broad market index rose 0.06% to close at 6,309.62, marking another record close for the index. The blue-chip Dow climbed 179.37 points, or 0.4%, to finish at 44,502.44. On the other hand, the tech-heavy Nasdaq Composite fell 0.39% to end the day at 20,892.69. — Sean Conlon U.S. President Donald Trump and Philippine President Ferdinand Marcos Jr., meet in the Oval Office at the White House in Washington, D.C., U.S., July 22, 2025. Kent Nishimura | Reuters President Donald Trump said on Tuesday that the U.S. has reached a trade agreement with the Philippines. "President Ferdinand Marcos, of the Philippines, is just leaving the White House, with all of his many Representatives. It was a beautiful visit, and we concluded our Trade Deal, whereby The Philippines is going OPEN MARKET with the United States, and ZERO Tariffs. The Philippines will pay a 19% Tariff," the president said in a Truth Social post. Trump also said that the two countries will "will work together Militarily." The Philippines has yet to confirm the deal. — Kevin Breuninger, Sean Conlon

White House releases U.S.-Indonesia trade deal framework, final talks underway
White House releases U.S.-Indonesia trade deal framework, final talks underway

CNBC

time5 hours ago

  • CNBC

White House releases U.S.-Indonesia trade deal framework, final talks underway

watch now The U.S. and Indonesia agreed to the framework of a trade agreement which would see Jakarta scrap most of its tariffs on American imports, the White House revealed in a joint statement Tuesday afternoon. U.S. tariffs on Indonesian imports would be set at 19% under the deal, which is described in the release as an "Agreement on Reciprocal Trade." While higher than the 10% baseline tariff that the U.S. has slapped on almost all other countries, the 19% rate is significantly lower than the 32% blanket duty that Indonesia initially faced under President Donald Trump's "liberation day" tariff plan in April. The joint statement notes that the U.S. and Indonesia will continue to "negotiate and finalize the Agreement on Reciprocal Trade" in the coming weeks. A worker processes soybeans to make tofu at a traditional tofu factory in Solo, Central Java, Indonesia, on May 1, 2025. Agoes Rudianto | Nurphoto | Getty Images They will also "prepare the Agreement for signature, and undertake domestic formalities in advance of the Agreement entering into force" in that time, the statement said. The newly unveiled terms of the framework mirror the ones Trump laid out when he first announced on social media last week that he had "finalized" a deal with Indonesia after speaking to its president, Prabowo Subianto. Tuesday's more formal statement said the framework also includes a series of forthcoming commercial deals between the two countries, including an aircraft purchase valued at $3.2 billion and an estimated $15 billion in purchases of energy products. The framework also says the countries will also address various "non-tariff barriers" and other obstacles that the U.S. faces in Indonesian markets. Indonesia is one of the United States' top 25 trade partners, with the two countries trading more than $38 billion in goods in 2024, according to the Commerce Department. The U.S. trade deficit with Indonesia totaled $17.9 billion last year. "Today's announcement shows that America can defend its domestic production while obtaining expansive market access with our trading partners," U.S. Trade Representative Jamieson Greer said in a statement. "American producers, who have long-faced high tariffs and burdensome requirements, will receive unprecedented access to Indonesia's market and greater certainty for the digital services sector. I thank Indonesian Minister Airlangga Hartarto for his dedication and I am glad we are able to achieve fair, balanced, and reciprocal trade for our countries," said Greer. The deal joins a limited number of other framework trade agreement outlines the Trump administration has released with countries that include the United Kingdom and China. This month, Trump announced that deals similar to Indonesia's had been reached with Vietnam and the Philippines. But the terms of those deals, as described by the White House, have not been confirmed by the participating nations. Trump has also sent a series of letters to key U.S. trade partners, laying out steep tariff rates he says will be imposed starting Aug. 1.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store